Clinic Software← All companies
Diabetes Reversal Group (DRG)
StageDebt
Raised$2.76M
Founded2009
Employees23
LocationDallas, TX
About
Diabetes Reversal Group® (DRG) was founded to provide a natural diabetes reversal treatment, non-drug approach to helping people with metabolic and nutritional imbalances. These imbalances can lead to many health problems traditionally treated with invasive prescription drug therapy, such as Type 2 Diabetes, Neuropathy and Heart Disease. The Patented Type 2 Diabetes Reversal program developed by DRG helps Type 2 Diabetes, by restoring proper metabolic function and nutritional balance. We have seen remarkable results with the improvement or elimination of these conditions, working in conjunction with your primary physician.
Product
- Value proposition
- A patented, clinically proven diabetes reversal system offering natural, non-drug treatment to reduce or eliminate need for diabetes medications, with guaranteed results.
- Target customers
- Clinics, healthcare providers, employers/workplace health programs, individual patients
- Regulatory
- Patent approved; regulatory pathway not detailed
Founders
- Dr. Jeffrey Hockings — Co-Founder / Chief Executive Officer
- Traci Hockings — Co-Founder / President / CHRO
- Sujata Kumaraswamy — Co-Founder
Categories
Products
Diabetes reversal programPATENTED diabetes reversal systemDRG Patient Portal
Key features
educates on diet, supplements, and exercise; reduces or eliminates medications; performance-backed guarantee
Technologies
patented systemnutritional protocolsdiabetes management program
Integrations
EHR integrations not specifieddrg partner portals listed
Target conditions
Type 2 diabetesDiabetes mellitusassociated conditions (blood pressure, cholesterol)
Care settings
clinicvirtualcare partner clinicspatient portal access
Certifications
Patent approval (patent)
Notable customers
Trusted by 10,000+ diabetics all over the world
Partnerships
Dr. Phil collaboration (educational/visibility partnership)Clinics/healthcare providers
Awards
Patent approval (not an award)
Traction metrics
82% reduced or eliminated medicationsHbA1C reductions (specific % figures: 81.75%, 82.48% 희)8.75%? (client HbA1C decrease) (text shows multiple partial numbers)
Competitors
not identified
Investors
Cerebain BiotechScott DuncanWill LukangHayden CookDavid Hamilton
News
- Diabetes Reversal Group 2026 Company Profile - PitchBook · 2025-06-30T00:00:00.000Z
- Advisory Board – DRG - DIABETES REVERSAL GROUP · 2024-11-22T00:00:00.000Z
- With Dr. Jeffrey M Hockings | The Business Spotlight - YouTube · 2025-03-18T00:00:00.000Z
- 11Alive News: The Take | Reversing diabetes? (11/3/25) - YouTube · 2025-11-03T00:00:00.000Z
- Scaling Diabetes Reversal with 2000 Licensed Practitioners - LinkedIn · 2026-06-01T00:00:00.000Z
- IMC and Diabetes Reversal Group Announce Strategic Partnership to Enhance Patient Outcomes · 2026-05-12T10:00:00.000Z
